Jumia Technologies AG - ADR vs Roivant Sciences Ltd. Common Shares — how do they compare? Jumia Technologies AG - ADR trades at $6.28 (market cap $865.90M), while Roivant Sciences Ltd. Common Shares trades at $35.1 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 28.5× Jumia Technologies AG - ADR's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Jumia Technologies AG - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Jumia Technologies AG - ADR for 28 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.
| JMIA | ROIV | |
|---|---|---|
Market Cap | $865.90M | $24.72B |
Volume | 1,695,227 | 6,279,442 |
Sector | Consumer Cyclical | Health |
52-Week High | $14.60 | $41.81 |
52-Week Low | $5.69 | $16.04 |
Typical Hold Time | 28 Days | 0 Days |
Enterprise Value | $831.54M | $20.99B |
Signals from Pluang's Aura AI — not financial advice
JMIA stock trades at $6.315, down 6.31% today, amid a bearish technical signal. The company reported revenue of $188.93M in 2025 with a net loss of $61.55M, though losses are narrowing year-over-year. Analyst consensus is bullish with a $12.00 price target, and recent news highlights a $50M capital raise and progress toward EBITDA breakeven by year-end 2026.
The outlook hinges on JMIA achieving profitability targets, with upside potential from analyst targets but risks from persistent losses and high valuation multiples. Execution on cost control and African e-commerce growth are critical for stock performance, while cash flow volatility remains a concern.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.
Read more on JMIA →Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →